The once-a-day table, elacestrant, will be prescribed to women with a gene mutation that makes traditional hormone-based treatments less effective. The once-a-day table, elacestrant, will be prescribed to women with a gene mutation that makes traditional hormone-based treatments less effective.
More than 1,000 women with advanced breast cancer set to get ‘more time with loved ones’ as daily pill to be free on NHS
